Surgical Principles in the Management of Lung Neuroendocrine Tumors: Open Questions and Controversial Technical Issues Debora BrasciaGiuseppe Marulli Neuroendocrine Cancers (M Cives, Section Editor) Open access 21 October 2022 Pages: 1645 - 1663
Management and Treatment of Non-small Cell Lung Cancer with MET Alteration and Mechanisms of Resistance Fedor MoiseenkoAlexey BogdanovVladimir Moiseyenko Lung Cancer (TA Leal and N Sethakorn, Section Editors) 21 October 2022 Pages: 1664 - 1698
Targeting KRASp.G12C Mutation in Advanced Non-Small Cell Lung Cancer: a New Era Has Begun Maristella BungaroSilvia NovelloFrancesco Passiglia Lung Cancer (TA Leal and N Sethakorn, Section Editors) 17 November 2022 Pages: 1699 - 1720
Adjuvant Immunotherapy in Patients with Early-Stage Non-small Cell Lung Cancer and Future Directions Stephanie PL SawMei-Kim AngDaniel SW Tan Lung Cancer (TA Leal and N Sethakorn, Section Editors) 01 December 2022 Pages: 1721 - 1731
Understanding Cancer Cachexia and Its Implications in Upper Gastrointestinal Cancers Leo R. BrownBarry J. A. LairdRichard J. E. Skipworth Upper Gastrointestinal Cancers (JD Berlin, Section Editor) Open access 21 October 2022 Pages: 1732 - 1747
Optimal First-Line Therapy for Metastatic Adenocarcinoma of the Esophagus Midhun MallaJacob FuquaRichard M. Goldberg Upper Gastrointestinal Cancers (JD Berlin, Section Editor) 22 October 2022 Pages: 1748 - 1760
Approach to Stereotactic Body Radiotherapy for the Treatment of Advanced Hepatocellular Carcinoma in Patients with Child-Pugh B-7 Cirrhosis Kayla M. DaniellKara Micah BansonShirin Sioshansi Upper Gastrointestinal Cancers (JD Berlin, Section Editor) Open access 05 November 2022 Pages: 1761 - 1774
Correction to: Approach to Stereotactic Body Radiotherapy for the Treatment of Advanced Hepatocellular Carcinoma in Patients with Child-Pugh B-7 Cirrhosis Kayla M. DaniellKara Micah BansonShirin Sioshansi Correction Open access 25 November 2022 Pages: 1775 - 1776
Cancer Immunotherapy: Fecal Microbiota Transplantation Brings Light Jie ZhangKanghui WuGuangming Li Lower Gastrointestinal Cancers (AB Benson, Section Editor) 24 October 2022 Pages: 1777 - 1792
Current Practice in Carcinoid Heart Disease and Burgeoning Opportunities Carrie LennemanDavid HarrisonLavanya Kondapalli Cardio-oncology (MG Fradley, Section Editor) 22 November 2022 Pages: 1793 - 1803
Targeted Therapies in the Treatment of Uterine Serous Carcinoma Joan R. Tymon-RosarioMegan GormanAlessandro D. Santin Gynecologic Cancers (JS Ferriss, Section Editor) 30 November 2022 Pages: 1804 - 1817
Contemporary Use of Hormonal Therapy in Endometrial Cancer: a Literature Review Aparna KailasamCarrie Langstraat Gynecologic Cancers (JS Ferriss, Section Editor) 22 November 2022 Pages: 1818 - 1828
Central Nervous System Prophylaxis and Treatment in Acute Leukemias Susan Y. WuNicholas J. ShortPenny Q. Fang Leukemia (PH Wiernik, Section Editor) Open access 13 December 2022 Pages: 1829 - 1844
Evaluating the Patient with Neurotoxicity after Chimeric Antigen Receptor T-cell Therapy Shannon P. Fortin EnsignCharles GaulinMaciej M. Mrugala Neuro-oncology (GJ Lesser, Section Editor) 16 December 2022 Pages: 1845 - 1860
Combinations of Chemotherapy and PD-1/PD-L1 Inhibitors in Sarcoma Meghan M. LynchBorislav A. AlexievSeth M. Pollack Sarcoma (SH Okuno, Section Editor) 16 November 2022 Pages: 1861 - 1876
Correction to: BRAF Inhibitor Resistance in Meslanoma: Mechanisms and Alternative Therapeutic Strategies Jingqin ZhongWangjun YanYong Chen Correction Open access 02 December 2022 Pages: 1877 - 1878
